Skip to main content
Treating patients with Ph+ CML since 2007. Over a decade of efficacy and safety data from clinical trials (See Full Prescribing Information).

Novartis Patient Support

Novartis Patient Support is a program designed to help your eligible patients start, stay, and save on TASIGNA. To learn more, call 1-800-282-7630.

Universal Co-pay Program
Novartis Universal Co-Pay Card
Patients may be eligible for immediate co-pay savings on their next prescription of TASIGNA.
 
  • Eligible patients with private insurance may pay $0 per month
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*


Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.

 

*Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756.

Novartis has another option for patients with Ph+ CML-CP who have previously tried 2 TKIs

Ph+ CML-CP,  Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase; TKIs, tyrosine kinase inhibitors.